Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	144
Overall Study	STARTED	Sotagliflozin 200 mg	141
Overall Study	STARTED	Sotagliflozin 400 mg	286
Overall Study	Treated	Placebo	144
Overall Study	Treated	Sotagliflozin 200 mg	141
Overall Study	Treated	Sotagliflozin 400 mg	285
Overall Study	COMPLETED	Placebo	129
Overall Study	COMPLETED	Sotagliflozin 200 mg	130
Overall Study	COMPLETED	Sotagliflozin 400 mg	249
Overall Study	NOT COMPLETED	Placebo	15
Overall Study	NOT COMPLETED	Sotagliflozin 200 mg	11
Overall Study	NOT COMPLETED	Sotagliflozin 400 mg	37

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03285594/flow